(Hypertension. 1999;33:378-384.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Angiotensin II Signaling in Vascular Smooth Muscle Cells Under High Glucose Conditions
From the Gonda Diabetes Center, City of Hope Medical Center, Duarte, Calif.
Correspondence to Rama Natarajan, PhD, Department of Diabetes, City of Hope Medical Center, 1500 E Duarte Rd, Duarte, CA 91010. E-mail rnatarajan{at}smtplink.coh.org
Abstract—The mechanisms responsible for the accelerated cardiovascular disease in diabetes, as well as the increased hypertrophic effects of angiotensin II (Ang II) under hyperglycemic conditions, are not very clear. We examined whether the culture of vascular smooth muscle cells (VSMC) under hyperglycemic conditions to simulate the diabetic state can lead to increased activation of key growth- and stress-related kinases, such as the mitogen-activated protein kinases (MAPKs), in the basal state and in response to Ang II. Treatment of porcine VSMC for short time periods (0.5 to 3 hours) with high glucose (HG; 25 mmol/L) markedly increased the activation of the extracellular signal–regulated kinase (ERK1/2) and c-Jun/N-terminal kinase (JNK) relative to cells cultured in normal glucose (NG; 5.5 mmol/L). p38 MAPK also was activated by HG, and this effect remained sustained for several hours. Ang II treatment increased the activity of all 3 families of MAPKs. Ang II–induced ERK activation was potentiated nearly 2-fold in cells treated with HG for 0.5 hour. However, Ang II–induced JNK was not altered. In VSMC cultured for 24 hours with HG, Ang II and HG displayed an additive response on p38 MAPK activity. MAPKs can lead to activation of transcription factors such as activator protein-1 (AP-1). HG alone significantly increased AP-1 DNA-binding activity. Furthermore, Ang II and HG combined had additive effects on AP-1 activity. These results suggest that increased activation of specific MAPKs and downstream transcription factors, such as AP-1, may be key mechanisms for the increased VSMC growth potential of HG alone and of Ang II under HG conditions.
Key Words: angiotensin II • hyperglycemia • diabetes mellitus • mitogen-activated protein kinases • activator protein-1 • muscle, smooth, vascular
This article has been cited by other articles:
 |
|
 |
|
  D.-S. Jung, J. J. Li, S.-J. Kwak, S. H. Lee, J. Park, Y. S. Song, T.-H. Yoo, S. H. Han, J. E. Lee, D. K. Kim, et al. FR167653 inhibits fibronectin expression and apoptosis in diabetic glomeruli and in high-glucose-stimulated mesangial cells Am J Physiol Renal Physiol, August 1, 2008; 295(2): F595 - F604. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, {alpha}v{beta}3-integrin, and TGF-{beta}1 in response to ANG II and high glucose Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H69 - H76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Cavet, E. M. Smolock, O. H. Ozturk, C. World, J. Pang, A. Konishi, and B. C. Berk Gas6-Axl Receptor Signaling Is Regulated by Glucose in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 886 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Spinetti, N. Kraenkel, C. Emanueli, and P. Madeddu Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies Cardiovasc Res, May 1, 2008; 78(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-H. Kim, H. Rincon-Choles, B. Bhandari, G. G. Choudhury, H. E. Abboud, and Y. Gorin Redox dependence of glomerular epithelial cell hypertrophy in response to glucose Am J Physiol Renal Physiol, March 1, 2006; 290(3): F741 - F751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rodriguez-Vita, E. Sanchez-Lopez, V. Esteban, M. Ruperez, J. Egido, and M. Ruiz-Ortega Angiotensin II Activates the Smad Pathway in Vascular Smooth Muscle Cells by a Transforming Growth Factor-{beta}-Independent Mechanism Circulation, May 17, 2005; 111(19): 2509 - 2517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sakowicz, A. Szutowicz, and T. Pawelczyk Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes Int. Immunol., February 1, 2005; 17(2): 145 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Devaraj, S. K. Venugopal, U. Singh, and I. Jialal Hyperglycemia Induces Monocytic Release of Interleukin-6 via Induction of Protein Kinase C-{alpha} and -{beta} Diabetes, January 1, 2005; 54(1): 85 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-W. Kang, R. Natarajan, A. Shahed, C. C. Nast, J. LaPage, P. Mundel, C. Kashtan, and S. G. Adler Role of 12-Lipoxygenase in the Stimulation of p38 Mitogen-Activated Protein Kinase and Collagen {alpha}5(IV) in Experimental Diabetic Nephropathy and in Glucose-Stimulated Podocytes J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3178 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Konishi and B. C. Berk Epidermal Growth Factor Receptor Transactivation Is Regulated by Glucose in Vascular Smooth Muscle Cells J. Biol. Chem., September 12, 2003; 278(37): 35049 - 35056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shanmugam, M. A. Reddy, M. Guha, and R. Natarajan High Glucose-Induced Expression of Proinflammatory Cytokine and Chemokine Genes in Monocytic Cells Diabetes, May 1, 2003; 52(5): 1256 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Sodhi, Y. S. Kanwar, and A. Sahai Hypoxia and high glucose upregulate AT1 receptor expression and potentiate ANG II-induced proliferation in VSM cells Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H846 - H852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Flores, S. Rojas, C. Aguayo, J. Parodi, G. Mann, J. D. Pearson, P. Casanello, and L. Sobrevia Rapid Stimulation of L-Arginine Transport by D-Glucose Involves p42/44mapk and Nitric Oxide in Human Umbilical Vein Endothelium Circ. Res., January 10, 2003; 92(1): 64 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and {beta}-Cell Dysfunction? Diabetes, January 1, 2003; 52(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yan, D. Kim, T. Aizawa, and B. C. Berk Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 26 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lin, A. Sahai, S. S. Chugh, X. Pan, E. I. Wallner, F. R. Danesh, J. W. Lomasney, and Y. S. Kanwar High Glucose Stimulates Synthesis of Fibronectin via a Novel Protein Kinase C, Rap1b, and B-Raf Signaling Pathway J. Biol. Chem., October 25, 2002; 277(44): 41725 - 41735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Endocr. Rev., October 1, 2002; 23(5): 599 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Startchik, D. Morabito, U. Lang, and M. F. Rossier Control of Calcium Homeostasis by Angiotensin II in Adrenal Glomerulosa Cells through Activation of p38 MAPK J. Biol. Chem., June 28, 2002; 277(27): 24265 - 24273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Reddy, P.-R. Thimmalapura, L. Lanting, J. L. Nadler, S. Fatima, and R. Natarajan The Oxidized Lipid and Lipoxygenase Product 12(S)-Hydroxyeicosatetraenoic Acid Induces Hypertrophy and Fibronectin Transcription in Vascular Smooth Muscle Cells via p38 MAPK and cAMP Response Element-binding Protein Activation. MEDIATION OF ANGIOTENSIN II EFFECTS J. Biol. Chem., March 15, 2002; 277(12): 9920 - 9928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tsiani, P. Lekas, I. G. Fantus, J. Dlugosz, and C. Whiteside High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E161 - E169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Fiordaliso, A. Leri, D. Cesselli, F. Limana, B. Safai, B. Nadal-Ginard, P. Anversa, and J. Kajstura Hyperglycemia Activates p53 and p53-Regulated Genes Leading to Myocyte Cell Death Diabetes, October 1, 2001; 50(10): 2363 - 2375. [Abstract] [Full Text]
|
|
|
|
|
|
R. Natarajan, M. A. Reddy, K. U. Malik, S. Fatima, and B. V. Khan Signaling Mechanisms of Nuclear Factor-{kappa}B-Mediated Activation of Inflammatory Genes by 13-Hydroperoxyoctadecadienoic Acid in Cultured Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1408 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Christopher, V. Velarde, D. Zhang, D. Mayfield, R. K. Mayfield, and A. A. Jaffa Regulation of B2-kinin receptors by glucose in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1537 - H1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P Montecinos, C. Aguayo, C. Flores, A. W Wyatt, J. D Pearson, G. E Mann, and L. Sobrevia Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase J. Physiol., December 15, 2000; 529(3): 777 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Chiming Wei, M. G Cardarelli, S. W Downing, and J. S McLaughlin The effect of angiotensin II on mitogen-activated protein kinase in human cardiomyocytes Journal of Renin-Angiotensin-Aldosterone System, December 1, 2000; 1(4): 379 - 384. [Abstract] [PDF]
|
|
|
|
|
|
M. Guha, W. Bai, J. L. Nadler, and R. Natarajan Molecular Mechanisms of Tumor Necrosis Factor alpha Gene Expression in Monocytic Cells via Hyperglycemia-induced Oxidant Stress-dependent and -independent Pathways J. Biol. Chem., June 2, 2000; 275(23): 17728 - 17739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Begum and L. Ragolia High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation Am J Physiol Cell Physiol, January 1, 2000; 278(1): C81 - C91. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Amiri, V. J. Venema, X. Wang, H. Ju, R. C. Venema, and M. B. Marrero Hyperglycemia Enhances Angiotensin II-induced Janus-activated Kinase/STAT Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., November 5, 1999; 274(45): 32382 - 32386. [Abstract] [Full Text] [PDF]
|
|